| abstract |
Disclosed are imidazopyridine derivatives of formula (I) or enantiomers, diastereomers, tautomers, solvates or pharmaceutically acceptable salts thereof, wherein the substituents are defined within the specification. Also disclosed are the compounds of formula (I) for the treatment or prophylaxis of disorders, diseases or conditions responsive to the inactivation of the melanocortin-4 receptor. |